One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects

One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects

Objective: EuCorVac-19 (ECV-19), an adjuvanted liposome-displayed receptor binding domain (RBD) COVID-19 vaccine, previously reported interim Phase 2 trial results showing induction of neutralizing antibodies 3 weeks after prime-boost immunization. The objective of this study was to determine the lo...

Full description

Bibliographic Details
Main Authors: Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, Chankyu Lee, Jeong-Yoon Lee, Young-Shin Park, Ingi Hong, Jung Hyuk Lee, Taewoo Kim, Sang Hwan Seo, Jae-Ouk Kim, Manki Song, Chung-Jong Kim, Jae-Ki Choi, Jieun Kim, Eun Ju Choo, Jung-Hyun Choi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
RBD
Vaccine
Liposome
Humoral immunity
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223007658

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223007658

Similar Items